(Q45862420)

English

The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin

scientific article published in June 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

0 references

0 references

author name string

E Seifried

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

G Gaedicke

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

G Pindur

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

H Rasche

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

publication date

1 June 1984

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

48

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

397-401

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic idiopathic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired Cell-Mediated Immunity in Patients with Classic Hemophilia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of anti-factor VIII antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter: A more uniform measurement of factor VIII inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of factor VIII antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihemophilic factor inhibitors. Management with prothrombin complex concentrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and course of inhibitors among patients with classic hemophilia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factor VIII Inhibitors and the Use of Blood Products in Patients with Haemophilia A

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic relationships of antihemophilic factor of different species detected by specific human and rabbit antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-therapy for haemophilia in Norway. Effect on transfusion frequency and days lost from work

1 reference

https://pubmed.ncbi.nlm.nih.gov/6430366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00319971

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/6430366

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45862420&oldid=2086803663"